{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:47:09Z","timestamp":1765284429570,"version":"3.46.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a rare but potentially severe manifestation in patients with connective tissue diseases (CTDs) like systemic lupus erythematosus (SLE). While immunosuppressive therapy is not indicated in most PAH subtypes, it plays a pivotal role in SLE-associated PAH due to its immune-mediated pathophysiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>This case report describes a 43-year-old woman with SLE who experienced two severe PAH flares, each following discontinuation of maintenance immunosuppression. The first episode was complicated by circulatory shock following \u03b2-blocker administration and treated with a combination of corticosteroids and pulmonary vasodilators. The second episode responded well to immunosuppressive therapy alone, without the need to escalate pulmonary vasodilator treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Both SLE-PAH flares followed discontinuation of maintenance immunosuppressive therapy, underscoring that continuous immunosuppression might reduce flare risk. The clinical course during flares aligns with evidence that SLE-associated PAH benefits from immunosuppression, in contrast to other PAH forms. Finally, the case highlights that negative chronotropic-inotropic agents (e.g. \u03b2-blockers) can induce life-threatening haemodynamic shock in patients with PAH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf620","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T13:02:02Z","timestamp":1764421322000},"source":"Crossref","is-referenced-by-count":0,"title":["When the immune system strikes twice: SLE-associated pulmonary arterial hypertension: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3742-0981","authenticated-orcid":false,"given":"Ana\u00efs","family":"Carlier","sequence":"first","affiliation":[{"name":"Medical Student, Ghent University , Sint-Pietersnieuwstraat 33, Ghent 9000 ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7945","authenticated-orcid":false,"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital , Corneel Heymanslaan 10, Ghent 9000 ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7697-3931","authenticated-orcid":false,"given":"Michel","family":"De Pauw","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ghent University Hospital , Corneel Heymanslaan 10, Ghent 9000 ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-0257","authenticated-orcid":false,"given":"Els","family":"Vandecasteele","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ghent University Hospital , Corneel Heymanslaan 10, Ghent 9000 ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2025120907411956600_ytaf620-B1","doi-asserted-by":"crossref","first-page":"e003674","DOI":"10.1136\/rmdopen-2023-003674","article-title":"Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol","volume":"10","author":"\u00c1lvarez Troncoso","year":"2024","journal-title":"RMD Open"},{"key":"2025120907411956600_ytaf620-B2","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025120907411956600_ytaf620-B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025120907411956600_ytaf620-B4","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.3390\/ijms24065085","article-title":"Systemic lupus erythematosus and pulmonary hypertension","volume":"24","author":"Parperis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025120907411956600_ytaf620-B5","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2025120907411956600_ytaf620-B6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2017.11.020","article-title":"Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: a review","volume":"134","author":"Bazan","year":"2018","journal-title":"Respir Med"},{"key":"2025120907411956600_ytaf620-B7","doi-asserted-by":"crossref","first-page":"104168","DOI":"10.1016\/j.lpm.2023.104168","article-title":"Pulmonary arterial hypertension","volume":"52","author":"Boucly","year":"2023","journal-title":"Presse Med"},{"key":"2025120907411956600_ytaf620-B8","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s10067-022-06446-y","article-title":"Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment","volume":"42","author":"Cansu","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2025120907411956600_ytaf620-B9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11739-024-03539-1","article-title":"Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis","volume":"19","author":"Erdogan","year":"2024","journal-title":"Intern Emerg Med"},{"key":"2025120907411956600_ytaf620-B10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"2025120907411956600_ytaf620-B11","doi-asserted-by":"crossref","first-page":"103506","DOI":"10.1016\/j.autrev.2023.103506","article-title":"Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): recent and advanced data","volume":"23","author":"Thoreau","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2025120907411956600_ytaf620-B12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1177\/0961203317702255","article-title":"Serological biomarkers as risk factors of SLE-associated pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus"},{"key":"2025120907411956600_ytaf620-B13","doi-asserted-by":"crossref","first-page":"e003703","DOI":"10.1161\/CIRCHEARTFAILURE.116.003703","article-title":"Use of \u03b2-blockers in pulmonary hypertension","volume":"10","author":"Perros","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2025120907411956600_ytaf620-B14","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology","volume":"25","author":"Gali\u00e8","year":"2004","journal-title":"Eur Heart J"},{"key":"2025120907411956600_ytaf620-B15","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT)","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf620\/65668632\/ytaf620.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf620\/65668632\/ytaf620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf620\/65668632\/ytaf620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:41:23Z","timestamp":1765284083000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf620\/8362394"}},"subtitle":[],"editor":[{"given":"Luca","family":"Monzo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kashimura","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Piera","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf620","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,27]]},"article-number":"ytaf620"}}